These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 18998037

  • 21. DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias.
    Leone G, Teofili L, Voso MT, Lübbert M.
    Haematologica; 2002 Dec; 87(12):1324-41. PubMed ID: 12495905
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
    Mai A, Altucci L.
    Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation.
    Reamon-Buettner SM, Borlak J.
    Reprod Toxicol; 2007 Jul; 24(1):20-30. PubMed ID: 17596910
    [Abstract] [Full Text] [Related]

  • 27. Epigenetic drugs take on cancer.
    Kaiser J.
    Science; 2010 Oct 29; 330(6004):576-8. PubMed ID: 21030620
    [No Abstract] [Full Text] [Related]

  • 28. Cancer treatment of the future: inhibitors of histone methyltransferases.
    Spannhoff A, Sippl W, Jung M.
    Int J Biochem Cell Biol; 2009 Jan 29; 41(1):4-11. PubMed ID: 18773966
    [Abstract] [Full Text] [Related]

  • 29. Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review).
    Emanuele S, Lauricella M, Tesoriere G.
    Int J Oncol; 2008 Oct 29; 33(4):637-46. PubMed ID: 18813776
    [Abstract] [Full Text] [Related]

  • 30. Epigenetic gene regulation in cancer.
    Ballestar E, Esteller M.
    Adv Genet; 2008 Oct 29; 61():247-67. PubMed ID: 18282509
    [Abstract] [Full Text] [Related]

  • 31. Novel approaches on epigenetics.
    Papait R, Monti E, Bonapace IM.
    Curr Opin Drug Discov Devel; 2009 Mar 29; 12(2):264-75. PubMed ID: 19333872
    [Abstract] [Full Text] [Related]

  • 32. Epigenetic tools in potential anticancer therapy.
    Sebova K, Fridrichova I.
    Anticancer Drugs; 2010 Jul 29; 21(6):565-77. PubMed ID: 20436342
    [Abstract] [Full Text] [Related]

  • 33. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.
    Lyko F, Brown R.
    J Natl Cancer Inst; 2005 Oct 19; 97(20):1498-506. PubMed ID: 16234563
    [Abstract] [Full Text] [Related]

  • 34. Acute myeloid leukemia: therapeutic impact of epigenetic drugs.
    Altucci L, Clarke N, Nebbioso A, Scognamiglio A, Gronemeyer H.
    Int J Biochem Cell Biol; 2005 Sep 19; 37(9):1752-62. PubMed ID: 15964234
    [Abstract] [Full Text] [Related]

  • 35. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis.
    Vogiatzi P, Vindigni C, Roviello F, Renieri A, Giordano A.
    J Cell Physiol; 2007 May 19; 211(2):287-95. PubMed ID: 17238139
    [Abstract] [Full Text] [Related]

  • 36. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
    Clark SJ.
    Hum Mol Genet; 2007 Apr 15; 16 Spec No 1():R88-95. PubMed ID: 17613553
    [Abstract] [Full Text] [Related]

  • 37. The necessity of a human epigenome project.
    Esteller M.
    Carcinogenesis; 2006 Jun 15; 27(6):1121-5. PubMed ID: 16699174
    [Abstract] [Full Text] [Related]

  • 38. Targeting epigenetic changes in acute myeloid leukemia.
    Blum W, Marcucci G.
    Clin Adv Hematol Oncol; 2005 Nov 15; 3(11):855-65, 882. PubMed ID: 16491631
    [Abstract] [Full Text] [Related]

  • 39. Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer.
    Botrugno OA, Santoro F, Minucci S.
    Cancer Lett; 2009 Aug 08; 280(2):134-44. PubMed ID: 19345000
    [Abstract] [Full Text] [Related]

  • 40. MS-275, a potent orally available inhibitor of histone deacetylases--the development of an anticancer agent.
    Hess-Stumpp H, Bracker TU, Henderson D, Politz O.
    Int J Biochem Cell Biol; 2007 Aug 08; 39(7-8):1388-405. PubMed ID: 17383217
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.